Elevance Health, Inc.
ELV
$289.10
$8.673.09%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -24.22% | -2.80% | -51.17% | -21.18% | 24.12% |
| Total Depreciation and Amortization | 13.43% | 12.69% | -28.74% | -22.77% | -22.63% |
| Total Amortization of Deferred Charges | -- | -- | 7.15% | -- | -- |
| Total Other Non-Cash Items | 163.95% | -36.76% | -187.62% | -86.92% | -317.76% |
| Change in Net Operating Assets | 88.85% | -80.67% | 99.59% | 491.43% | -341.31% |
| Cash from Operations | 359.51% | -48.58% | 123.76% | 2.45% | -77.08% |
| Capital Expenditure | 17.34% | 29.75% | 1.23% | -4.08% | 7.71% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 1,450.00% | -- | -20,572.22% | -100.00% | 69.23% |
| Divestitures | -101.00% | -- | -- | -- | -- |
| Other Investing Activities | 47.19% | 132.38% | 433.56% | 84.63% | -188.03% |
| Cash from Investing | 16.01% | 104.46% | -59.18% | 41.63% | -21.73% |
| Total Debt Issued | -80.49% | -46.48% | 1,385.84% | -- | 511.69% |
| Total Debt Repaid | 2.80% | -132.94% | -390.78% | -188.32% | 171.81% |
| Issuance of Common Stock | -- | -76.29% | -60.00% | 54.84% | 57.89% |
| Repurchase of Common Stock | 35.85% | -50.60% | -95.47% | 86.25% | 28.44% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.85% | -1.85% | -7.80% | -8.62% | -8.00% |
| Other Financing Activities | -25.00% | -450.00% | -450.00% | -- | 33.33% |
| Cash from Financing | -146.11% | -6,065.63% | 457.36% | 7.95% | 146.71% |
| Foreign Exchange rate Adjustments | 120.00% | -- | -900.00% | 275.00% | -600.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 291.14% | -162.67% | 109.61% | 47.52% | 279.47% |